1. Facilitating Drug Discovery in Breast Cancer by Virtually Screening Patients Using In Vitro Drug Response Modeling
   Robert F. Gruener et al, 2021, Cancers CrossRef
2. Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
   Shengliang Zhang et al, 2022, Biomolecules CrossRef
3. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
   Siyao Deng et al, 2022, Cancers CrossRef
4. An update of predictive biomarkers related to WEE1 inhibition in cancer therapy
   Zizhuo Wang et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
5. Discovery of Synergistic Drug Combinations for Colorectal Cancer Driven by Tumor Barcode Derived from Metabolomics “Big Data”
   Bo Lv et al, 2022, Metabolites CrossRef
6. Mutant p53 in Cancer Progression and Targeted Therapies
   Gaoyang Zhu et al, 2020, Frontiers in Oncology CrossRef
7. WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma
   Sarah J. Hartman et al, 2021, Frontiers in Oncology CrossRef
8. Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
   Caroline Molinaro et al, 2021, Cancers CrossRef
9. Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer
   Paula Pellenz Tomasini et al, 2021, Cancers CrossRef